Pharma News Intelligence January 30, 2024
Veronica Salib

Deloitte researchers evaluate the importance of digitizing the biopharmaceutical supply chain in establishing the industry’s future.

Throughout the past few years, global, national, and industry-specific changes have posed challenges to the biopharmaceutical supply chain. Disruptions and shortages have caused industry leaders and regulatory organizations to look for alternative solutions to restore and enhance these supply chains, building resilience in anticipation of future challenges.

Recently, the Deloitte Center for Health Solutions surveyed over 100 biopharmaceutical leaders to understand how supply chain digitization can address ongoing hurdles. PharmaNewsIntelligence interviewed Laks Pernenkil, PhD, Principal and Practice Leader, US Life Sciences Product and Supply Operations, to discuss the survey results and the facets of a digitized biopharmaceutical supply chain.

Biopharmaceutical Supply Chain Challenges

Pernenkil...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Survey / Study, Technology, Trends
Related Articles:
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
What's next for Amazon in healthcare?
How has U.S. Spending on Health Care Changed Over Time?
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health

Share This Article